Navigation Links
Halving daily cigarette quota has no health benefit

Halving the number of cigarettes smoked every day in the belief that it will stave off an early death makes no difference, suggests research in Tobacco Control.

Although reducing consumption may have a place as a temporary measure in smoking cessation, this study proves quite clearly that the only safe way out of the risk caused by smoking is to quit, say the authors.

They base their findings on more than 51,000 men and women, all of whom were aged between 20 and 34 at the start of the study.

Participants were initially assessed for cardiovascular risk factors, and then screened again twice at an interval of three to 10 years, adding up to an average monitoring period of over two decades.

Participants were classified as never smokers; ex smokers, quitters (those who gave up between the first and second check); moderate smokers (1 to 14 cigarettes daily); reducers (more than 15 cigarettes a day, cut by more than half at the second check); and heavy smokers (more than 15 cigarettes a day).

Among men, deaths from lung cancer and cancers associated with smoking were not significantly lower in those who had cut back compared with heavy smokers. But this was not true of women who cut back, where the reverse was true.

And men who cut back only had slightly lower death rates from all causes combined than the heavy smokers during the first 15 years. After that, death rates were comparable.

And there were no significant differences in death rates from specific causes, including early death from cardiovascular disease, among women who cut back their daily consumption, compared with those who continued to smoke heavily.

Women who cut back actually had higher death rates from all causes combined than heavy smokers.

The authors conclude that long term monitoring provides no evidence that heavy smokers, who halve their daily cigarette consumption, significantly cut their risk of early death. T
'"/>

Source:BMJ Specialty Journals


Page: 1 2

Related biology news :

1. Re-analysis of cigarettes confirms tobacco companies increased addictive nicotine 11 percent
2. New cigarette designs dont offer lower predicted cancer risks
3. Chemists create Superbowl molecule; May lead to better health
4. New push for public health, AIDS spending at African Union summit
5. Scientists collaborate to assess health of global environment
6. Highly adaptable genome in gut bacterium key to intestinal health
7. Genetically modified rice in China benefits farmers health, study finds
8. How the environment could be damaging mens reproductive health
9. Mutation in clams protects against paralytic shellfish poisoning but raises human health risk
10. Study of energy and health in Africa focuses spotlight on charcoal and forest management
11. Genome study of beneficial microbe may help boost plant health

Post Your Comments:
(Date:11/25/2009)...ital to your health as what you eat, found researc... Their experiments in mice revealed that the daily...verthe body,s metabolic clearinghouseis mostly con...dian clock as conventional wisdom had it. , "If...umber of genes completely independent of the circa...
(Date:11/24/2009)...es from collapsing have been true life-savers. But...ed -- once the arteries are strengthened, they bec... but to leave them in place. , Prof. Meital Zilb...dical Engineering has developed a new patent-pendi... needed, then dissolves. , "Our new composite fi...
(Date:11/24/2009)...debate. A high-profile study a few years ago sugge...on from trees and leaves, evidence for a very clos...ems. , But new research from the University of W...ae provide a much richer diet for fish and other a...week in the Proceedings of the National Academy o...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 1Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 2Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 4762 3Go to the doctor 3F Only if Im really sick 52314 1Go to the doctor 3F Only if Im really sick 52314 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 1Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 2Michael J Fox Foundation Awards 243 8 Million To Drive Nine Industry Partnerships For Pre Clinical Parkinsons Drug Development 52311 3
...ngs about the causes of mad cow disease show that ...also in the genes of cattle," said Juergen A. Rich...edicine and Pathobiology at Kansas State Universit...al years ago, Richt said, it was thought that the ...thy -- also called BSE or mad cow disease -- was a...
...Stevens Institute of Technology has been awarded a...e project, "MRI: Acquisition of an Inductively Cou...abrication." The Stevens team includes Yong Shi, t...gineering department; Stefan Strauf, a Professor t...e Professor in the Mechanical Engineering departme...
...t Service Southern Research Station (SRS) today an...t Disturbances: Wildfires, Storms, and Invasive Sp...ffers a synthesis of new approaches to understandi...s. , The Economics of Forest Disturbances is th...e framework for analyzing the economic effects of ...
Other Biology News:K-State professor's USDA research shows mad cow disease also caused by genetic mutation 2NSF awards two grants to Stevens for nano/micro device fabrication and nano sensor development 2Book breaks new ground in the study of economics and forest threats management 2
(Date:11/24/2009)..., , REDWOOD CITY, Calif., Nov. 24 /PRNe... GHDX ) today announced that Randy Scott, Genomic...21st Annual Piper Jaffray Health Care Conference i...:00 a.m. ET. ,, To access the live and subsequ...the Investor Relations section of Genomic Health,s...
(Date:11/24/2009)..., Program Connects Custom... Samples Collected with DNA Genotek Products , ...24, 2009 -- DNA Genotek , a leading provider of p...ation and preparation, today announced its new glo...t enhancements for DNA Genotek,s partner community...
(Date:11/24/2009)..., , SEATTLE, Nov. 24 /PRNewswire-Firs...d MTA: CTIC) management will present at the 21st A...nference will be held December 1-2, 2009, at the N...Tuesday, December 1 at 11:00 a.m. Eastern Time in ...s presentation will be available at www.cellthera...
(Date:11/23/2009)..., CHAMPAIGN, Ill. You can think of it as origami...iversity of Illinois have developed a technique fo...e silicon structures from thin films by coupling p...by capillary interactions. , The films, only a fe... is not possible with thicker pieces of the same m...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
... 12 Anthera Pharmaceuticals, Inc., a,privately he...mmatory drugs,announced today that it has complete...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib (A-0...of an Acute,Coronary Syndrome (ACS) event. , "...
... Pharmasset, Inc. (Nasdaq: VRUS ) announced toda...have agreed with the FDA on the final design for a... of hepatitis C (HCV), slated to initiate in the f...at R7128 is advancing into a large phase 2b trial,...ief Medical Officer. "R7128 is the most advanced n...
...nuary 12 , - Reflects Strong International Gr...ding IP Management Specialist and Legal Support Se...llectual property,( http://www.cpaglobal.com ) (IP...outsourced legal support services, has today marke...ew brand worldwide. , Founded in 1969 as a spe...
Other Biology Technology:Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 2Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 2Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 4Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 5CPA Global Marks 40th Anniversary With Launch of New Brand 2CPA Global Marks 40th Anniversary With Launch of New Brand 3
GIBCO Fetal Bovine Serum Heat-Inactivated from Invitrogen
Mouse Anti-EGFr VIII Antibody, Unconjugated from Invitrogen
Custom siRNA, PAGE purified from Ambion
GIBCO Kanamycin Sulfate from Invitrogen
Biology Products: